Upregulation of the CXCL9 family of chemokines was also seen in 5-month-old CRC tumors of mice receiving i.p. injections of anti-IL-17A neutralizing antibody, demonstrating the effect of acute IL-17A blockade in chemokine production (Fig. 3c). This evidence concerns the gene CXCL9 and colorectal carcinoma.